NYXH logo

Nyxoah SA (NYXH)

Profile

Full Name

Nyxoah S.A.

Ticker Symbol

NYXH

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Belgium

IPO

April 28, 2021

Indexes

Not included

Website

http://www.nyxoah.com

Employees

183

Key Details

Price

$5.98(-2.76%)

Market cap

$223.82M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.89M(+3.95% YoY)

Annual EPS

-$1.96(-17.06% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.98
NYXH price is $5.98

30-Day Relative Volume

1.63
NYXH 30-day relative volume is 1.63

Price Performance

Price Most recent change

-2.76%
NYXH price was down -2.76% on Apr 14, 2025

Price YTD change

-25.25%
NYXH price is down -25.25% since January 1st

Price 1-year change

-32.81%
NYXH price is down -32.81% year-on-year

Price 3-year change

-68.53%
NYXH price is down -68.53% over the past 3 years

Price Range

Price All-time high

$37.00
NYXH price is currently -83.84% below its historical high of $37.00

Price 3-year low

$4.00
NYXH price is currently +49.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$223.82M
NYXH market capitalization is $223.82 million

Market cap 3-year change

-54.34%
NYXH market capitalization is down -54.34% over the past 3 years

Market cap All-time high

$941.20M
NYXH market capitalization is currently -76.22% below its historical high of $941.20 million

Market cap sector rank

58.72%
NYXH market capitalization is higher than 58.72% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+30.49%
NYXH shares outstanding is up +30.49% year-on-year

Shares Outstanding 3-Year Change

+45.08%
NYXH shares outstanding is up +45.08% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.58
NYXH beta is 0.58

200-day SMA

$8.88
NYXH price is currently -32.69% below its 200-day simple moving average

50-day SMA

$9.41
NYXH price is currently -36.44% below its 50-day simple moving average

RSI

29.15
NYXH 14-day relative strength index is 29.15

Volume

1.63
NYXH 30-day relative volume is 1.63

ATR

$0.65
NYXH average true range is $0.65

10-day Historical Volatility

98.95%
NYXH 10-day historical volatility is 98.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.89M
NYXH annual revenue is $4.89 million

Revenue Analysts estimate

$19.09M
NYXH annual revenue is currently -74.36% lower than the consensus analysts' forecast

Revenue 1-year change

+3.95%
NYXH annual revenue is up +3.95% year-on-year

Revenue Sector rank

21.5%
NYXH annual revenue is higher than 21.5% of companies in Healthcare sector

EPS

EPS

-$1.96
NYXH annual earnings per share is -$1.96

EPS Analysts estimate

-$2.09
NYXH annual earnings per share is currently -6.24% lower than the consensus analysts' forecast

EPS 1-year change

-17.06%
NYXH annual earnings per share is down -17.06% year-on-year

EPS Sector rank

39.12%
NYXH annual earnings per share is higher than 39.12% of companies in Healthcare sector

Profit

Gross profit

$3.21M
NYXH annual gross profit is $3.21 million

Gross margin

65.67%
NYXH annual gross profit margin is 65.67%

Operating profit

-$63.65M
NYXH annual operating income is -$63.65 million

Operating margin

-1300.80%
NYXH annual operating profit margin is -1300.80%

Net income

-$64.11M
NYXH annual net profit is -$64.11 million

Net margin

-1310.24%
NYXH annual net profit margin is -1310.24%

Expenses

Total expenses

$68.55M
NYXH annual total expenses is $68.55 million

Operating expenses

$66.87M
NYXH annual total operating expenses is $66.87 million

Cost of goods sold

$1.68M
NYXH annual cost of goods sold is $1.68 million

Selling, general & administrative expenses

$30.80M
NYXH annual SGA is $30.80 million

Depreciation and amortization

$2.94M
NYXH annual depreciation & amortization is $2.94 million

Interest expense

$5.49M
NYXH annual interest expense is $5.49 million

Income tax

$3.03M
NYXH annual income tax is $3.03 million

EBIT & EBITDA

EBIT

-$55.59M
NYXH annual earnings before interest & taxes is -$55.59 million

EBITDA

-$55.59M
NYXH annual EBITDA is -$55.59 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$164.83M
NYXH annual total assets is $164.83 million

Non current assets

$62.77M
NYXH annual long term assets is $62.77 million

Current assets

$102.06M
NYXH annual total current assets is $102.06 million

Cash and cash equivalents

$35.57M
NYXH annual cash & cash equivalents is $35.57 million

Accounts receivable

$3.52M
NYXH annual accounts receivable is $3.52 million

Inventory

$4.91M
NYXH annual inventory is $4.91 million

Liabilities

Total liabilities

$46.98M
NYXH annual total liabilities is $46.98 million

Long term liabilities

$24.58M
NYXH annual total long term liabilities is $24.58 million

Current liabilities

$22.40M
NYXH annual total current liabilities is $22.40 million

Accounts payable

$9.89M
NYXH annual accounts payable is $9.89 million

Debt

Total debt

$23.57M
NYXH annual total debt is $23.57 million

Total debt 1-year change

+67.86%
NYXH annual total debt is up +67.86% year-on-year

Long term debt

$22.15M
NYXH annual long term debt is $22.15 million

Short term debt

$1.42M
NYXH annual short term debt is $1.42 million

Equity & Capital

Shareholders equity

$117.85M
NYXH annual stockholders equity is $117.85 million

Book value

$117.85M
NYXH annual book value is $117.85 million

Retained earnings

-$226.57M
NYXH annual retained earnings is -$226.57 million

Working capital

$79.66M
NYXH annual working capital is $79.66 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$53.28M
NYXH annual cash flow from operations is -$53.28 million

Cash from operations 1-year change

-9.91%
NYXH annual cash flow from operations is down -9.91% year-on-year

Cash from investing

-$17.67M
NYXH annual cash flow from investing activities is -$17.67 million

Cash from investing 1-year change

-150.99%
NYXH annual cash flow from investing activities is down -150.99% year-on-year

Cash from financing

$83.82M
NYXH annual cash flow from financing activities is $83.82 million

Cash from financing 1-year change

+359.25%
NYXH annual cash flow from financing activities is up +359.25% year-on-year

CAPEX

CAPEX

$6.57M
NYXH annual capital expenditures is $6.57 million

CAPEX 1-year change

-44.62%
NYXH annual capital expenditures is down -44.62% year-on-year

Free Cash Flow

Free cash flow

-$59.85M
NYXH annual free cash flow is -$59.85 million

Free cash flow 1-year change

+0.82%
NYXH annual free cash flow is up +0.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

65.67%
NYXH annual gross profit margin is 65.67%

Operating margin

-1300.80%
NYXH annual operating profit margin is -1300.80%

Net margin

-1310.24%
NYXH annual net profit margin is -1310.24%

ROA & ROE

ROA

-42.45%
NYXH annual return on assets is -42.45%

ROE

-56.69%
NYXH annual return on equity is -56.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NYXH price to earnings ratio value is unknown

PE ratio Sector rank

-
NYXH price to earnings ratio is unknown

PB Ratio

PB ratio

1.90
NYXH price to book ratio is 1.90

PB ratio Sector rank

60.99%
NYXH price to book ratio is higher than 60.99% of companies in Healthcare sector

PS Ratio

PS ratio

45.72
NYXH price to sales ratio is 45.72

PS ratio Sector rank

91.92%
NYXH price to sales ratio is higher than 91.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$211.81M
NYXH enterprise value is $211.81 million

Enterprise value Sector rank

59.83%
NYXH enterprise value is higher than 59.83% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.71
NYXH EV/EBITDA is -3.71

EV/EBITDA Sector rank

22.52%
NYXH EV/EBITDA is higher than 22.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.56
NYXH annual current ratio is 4.56

Quick ratio

4.34
NYXH annual quick ratio is 4.34

Leverage

Debt to equity

0.17
NYXH annual debt to equity ratio is 0.17

Interest coverage ratio

-10.13
NYXH annual interest coverage ratio is -10.13

Risk & Stability

Piotroski F-Score

-
NYXH piotroski f-score value is unknown

Altman Z-Score

0.43
NYXH altman z-score is 0.43

Analyst ratings

Recent major analysts updates

Apr 8, 25 HC Wainwright & Co.
Buy
Mar 26, 25 HC Wainwright & Co.
Buy
Mar 14, 25 Stifel
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Nov 5, 24 Cantor Fitzgerald
Overweight
Oct 11, 24 HC Wainwright & Co.
Buy
Sep 30, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Oppenheimer
Outperform
Aug 7, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

MBX Biosciences (MBX)
NVRO logo
Nevro (NVRO)
OSUR logo
OraSure Technologies (OSUR)
YMAB logo
Y-mAbs Therapeutics (YMAB)
QSI logo
Quantum-Si incorporated (QSI)
Acelyrin (SLRN)
LFCR logo
Lifecore Biomedical (LFCR)
LFMD logo
LifeMD (LFMD)
NVCT logo
Nuvectis Pharma (NVCT)
  • What is the ticker symbol for Nyxoah SA?
  • Does Nyxoah SA pay dividends?
  • What sector is Nyxoah SA in?
  • What industry is Nyxoah SA in?
  • What country is Nyxoah SA based in?
  • When did Nyxoah SA go public?
  • Is Nyxoah SA in the S&P 500?
  • Is Nyxoah SA in the NASDAQ 100?
  • Is Nyxoah SA in the Dow Jones?
  • When was Nyxoah SA's last earnings report?
  • When does Nyxoah SA report earnings?

What is the ticker symbol for Nyxoah SA?

The ticker symbol for Nyxoah SA is NASDAQ:NYXH

Does Nyxoah SA pay dividends?

No, Nyxoah SA does not pay dividends

What sector is Nyxoah SA in?

Nyxoah SA is in the Healthcare sector

What industry is Nyxoah SA in?

Nyxoah SA is in the Medical Instruments & Supplies industry

What country is Nyxoah SA based in?

Nyxoah SA is headquartered in Belgium

When did Nyxoah SA go public?

Nyxoah SA's initial public offering (IPO) was on April 28, 2021

Is Nyxoah SA in the S&P 500?

No, Nyxoah SA is not included in the S&P 500 index

Is Nyxoah SA in the NASDAQ 100?

No, Nyxoah SA is not included in the NASDAQ 100 index

Is Nyxoah SA in the Dow Jones?

No, Nyxoah SA is not included in the Dow Jones index

When was Nyxoah SA's last earnings report?

Nyxoah SA's most recent earnings report was on Mar 13, 2025

When does Nyxoah SA report earnings?

The next expected earnings date for Nyxoah SA is May 13, 2025
On this page